Sequent Scientific Ltd

Sequent Scien. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sequent Scientific Ltd

₹ 125 -0.04%
26 Apr - close price
sequent.in BSE: 512529 NSE : SEQUENT
About

Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging portfolio of animal health products, including Finished Dose Formulations, APIs, as well as analytical services to the pharmaceutical and life sciences industries.

Key Points

Business segment & Revenue Mix FY22
The company has 2 business segments: Formulation and API. [1]

Website BSE NSE
  • Market Cap ₹ 3,119 Cr.
  • Current Price ₹ 125
  • High / Low ₹ 156 / 70.2
  • Stock P/E 2,136
  • Book Value ₹ 42.6
  • Dividend Yield 0.00 %
  • ROCE -0.68 %
  • ROE -0.58 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Debtor days have improved from 64.7 to 22.4 days.

Cons

  • Stock is trading at 2.93 times its book value
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 1.37% over last 3 years.
  • Earnings include an other income of Rs.34.8 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
68.46 69.48 46.66 50.11 59.19 63.67 64.86 54.23 57.00 46.60 40.42 49.12 42.21
55.81 66.60 50.81 54.69 56.41 58.45 66.85 63.81 65.74 52.64 49.50 56.82 46.36
Operating Profit 12.65 2.88 -4.15 -4.58 2.78 5.22 -1.99 -9.58 -8.74 -6.04 -9.08 -7.70 -4.15
OPM % 18.48% 4.15% -8.89% -9.14% 4.70% 8.20% -3.07% -17.67% -15.33% -12.96% -22.46% -15.68% -9.83%
5.67 6.01 5.76 10.41 5.70 5.77 5.88 6.73 7.62 8.01 3.45 9.87 13.44
Interest 0.60 0.25 0.17 0.28 0.56 0.61 0.35 0.58 0.72 0.87 0.98 1.21 1.15
Depreciation 2.19 2.61 2.31 2.54 2.40 2.34 2.38 2.25 2.15 2.33 2.43 2.35 2.05
Profit before tax 15.53 6.03 -0.87 3.01 5.52 8.04 1.16 -5.68 -3.99 -1.23 -9.04 -1.39 6.09
Tax % 24.47% 23.05% 31.03% -42.52% 18.84% 17.16% 27.59% 28.70% 69.42% -34.15% 24.67% 34.53% 24.79%
11.73 4.64 -0.61 4.29 4.47 6.65 0.84 -4.05 -1.23 -1.65 -6.80 -0.92 4.58
EPS in Rs 0.47 0.19 -0.02 0.17 0.18 0.27 0.03 -0.16 -0.05 -0.07 -0.27 -0.04 0.18
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
332 236 341 384 395 91 106 166 227 265 220 223 178
297 254 347 330 358 121 124 164 205 230 220 249 205
Operating Profit 35 -19 -6 54 36 -31 -18 3 22 35 -1 -26 -27
OPM % 11% -8% -2% 14% 9% -34% -17% 2% 10% 13% -0% -12% -15%
11 3 -55 57 15 34 432 14 15 17 28 28 35
Interest 28 25 31 43 16 0 0 3 5 3 2 3 4
Depreciation 21 23 23 25 24 3 4 7 9 9 10 9 9
Profit before tax -2 -63 -114 43 10 -0 409 6 23 41 16 -10 -6
Tax % 159% 13% 0% 4% 1% 0% 1% -22% 6% 21% 6% 38%
1 -54 -114 41 10 -0 406 8 21 32 15 -6 -5
EPS in Rs 0.13 -4.54 -8.38 2.71 0.44 -0.00 16.68 0.31 0.86 1.29 0.60 -0.24 -0.20
Dividend Payout % 0% 0% 0% 0% 0% 0% 1% 65% 0% 39% 0% 0%
Compounded Sales Growth
10 Years: -1%
5 Years: 16%
3 Years: -1%
TTM: -26%
Compounded Profit Growth
10 Years: 7%
5 Years: %
3 Years: %
TTM: -34%
Stock Price CAGR
10 Years: 10%
5 Years: 12%
3 Years: -24%
1 Year: 69%
Return on Equity
10 Years: 6%
5 Years: 1%
3 Years: 1%
Last Year: -1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 21 23 27 30 48 49 49 49 50 50 50 50 50
Reserves 105 74 13 98 1,145 1,209 900 868 837 980 991 1,008 1,013
222 265 350 341 49 87 0 44 35 6 17 20 33
148 177 171 181 107 106 29 57 76 67 66 44 61
Total Liabilities 496 540 560 650 1,348 1,450 977 1,019 997 1,102 1,124 1,123 1,157
206 205 220 201 170 188 24 52 69 66 67 57 45
CWIP 18 22 11 9 20 32 3 0 4 4 1 2 6
Investments 39 55 65 183 897 891 687 788 758 685 659 633 637
233 259 264 257 262 340 264 178 167 347 397 431 470
Total Assets 496 540 560 650 1,348 1,450 977 1,019 997 1,102 1,124 1,123 1,157

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
10 -13 -42 -25 100 -24 -4 74 30 2 9 38
-40 -31 -61 24 -359 -47 16 -114 -18 17 -4 -51
32 39 108 8 247 71 -12 40 -11 -21 7 0
Net Cash Flow 2 -5 4 7 -12 0 -0 0 2 -2 12 -13

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 91 109 85 94 68 455 270 94 65 84 87 22
Inventory Days 121 228 196 126 94 315 64 98 101 154 228 129
Days Payable 236 402 262 132 123 352 113 203 208 197 193 99
Cash Conversion Cycle -24 -66 19 88 39 417 221 -11 -41 41 122 53
Working Capital Days 1 16 51 55 129 795 333 55 17 73 114 71
ROCE % 6% -11% -6% 26% 3% 0% 35% 1% 3% 5% 2% -1%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
53.86% 53.52% 53.02% 53.02% 52.79% 52.79% 52.79% 52.79% 52.79% 52.79% 52.79% 52.79%
13.60% 14.12% 6.42% 5.84% 6.45% 6.57% 6.25% 5.89% 6.27% 6.03% 6.12% 6.16%
2.49% 2.03% 2.13% 2.04% 2.27% 2.79% 2.81% 2.92% 2.92% 3.23% 7.23% 7.59%
29.46% 29.73% 37.89% 38.60% 38.10% 37.48% 37.76% 38.00% 37.64% 37.57% 33.69% 33.29%
0.60% 0.60% 0.54% 0.51% 0.39% 0.39% 0.39% 0.39% 0.39% 0.39% 0.17% 0.17%
No. of Shareholders 86,8481,24,0141,67,8121,91,0921,97,1761,93,9541,96,2311,91,8751,87,4741,84,5211,72,8531,66,593

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls